Treatment strategies for insomnia in Japanese primary care physicians' practice: A Web-based questionnaire survey.

Journal: BMC primary care

Volume: 25

Issue: 1

Year of Publication: 2024

Affiliated Institutions:  Department of Neuropsychiatry, Akita University Graduate School of Medicine, Akita City, Japan. Department of Neuropsychiatry, Kyorin University Faculty of Medicine, Tokyo, Japan. Department of Psychiatry, Kitasato University School of Medicine, Sagamihara City, Japan. Psychiatric and Mental Health Nursing, Graduate School of Nursing Science, St. Luke's International University, Tokyo, Japan. Department of General Internal Medicine, St. Marianna University School of Medicine, Kawasaki City, Japan. Centre for Family Medicine Development, Japanese Health and Welfare Co-Operative Federation, Tokyo, Japan. Department of General Internal Medicine, Kawasaki Kyodo Hospital, Kawasaki Health Cooperative Association, Kawasaki City, Japan. Department of Clinical Laboratory, National Center of Neurology and Psychiatry, National Center Hospital, Tokyo, Japan. Department of Sleep-Wake Disorders, National Center of Neurology and Psychiatry, National Institute of Mental Health, Tokyo, Japan. Department of Psychiatry, Tokyo Medical University, Tokyo, Japan. Department of Psychological Counseling, Faculty of Humanities, Tokyo Kasei University, Tokyo, Japan. Kotorii Isahaya Hospital, Isahaya City, Japan. Minnano Sleep and Stress Care Clinic, Hiroshima City, Japan. Department of Psychiatry, Nihon University School of Medicine, Tokyo, Japan. Research Center for Child Mental Development, Chiba University, Chiba City, Japan. Department of Neuropsychiatry, Kyorin University Faculty of Medicine, Tokyo, Japan. takaesuy@med.u-ryukyu.ac.jp.

Abstract summary 

It is unclear how primary care physicians manage insomnia after the introduction of novel hypnotics such as orexin receptor antagonists and melatonin receptor agonists. This Web-based questionnaire survey aimed to examine treatment strategies for insomnia in Japanese primary care practice.One-hundred-and-seventeen primary care physicians were surveyed on the familiarity of each management option for insomnia on a binary response scale (0 = "unfamiliar"; 1 = "familiar") and how they managed insomnia using a nine-point Likert scale (1 = "I never prescribe/perform it"; 9 = "I often prescribe/perform it"). Physicians who were unfamiliar with a management option were deemed to have never prescribed or performed it.Regarding medication, most physicians were familiar with novel hypnotics. Suvorexant was the most used hypnotic, followed by lemborexant and ramelteon. These novel hypnotics averaged 4.8-5.4 points and 4.0-4.7 points for sleep onset and sleep maintenance insomnia, respectively. By contrast, most benzodiazepines were seldom used below two points. Regarding psychotherapy, only approximately 40% of the physicians were familiar with cognitive behavioral therapy for insomnia (CBT-I) and they rarely implemented it, at an average of 1.5-1.6 points. More physicians were familiar with single-component psychotherapies (i.e., relaxation, sleep restriction therapy, and stimulus control) compared to CBT-I, and 48-74% of them implemented it slightly more often, with scores ranging from 2.6 to 3.4 points.This study suggests that Japanese primary care physicians seldom use CBT-I to treat insomnia. In addition, they use novel sleep medications more frequently than benzodiazepines in terms of pharmacotherapy. The use and availability of CBT-I in Japanese primary care might be facilitated by: educating primary care physicians, implementing brief or digital CBT-I, and/or developing collaborations between primary care physicians and CBT-I specialists.

Authors & Co-authors:  Takeshima Masahiro M Sakurai Hitoshi H Inada Ken K Aoki Yumi Y Ie Kenya K Kise Morito M Yoshida Eriko E Matsui Kentaro K Utsumi Tomohiro T Shimura Akiyoshi A Okajima Isa I Kotorii Nozomu N Yamashita Hidehisa H Suzuki Masahiro M Kuriyama Kenichi K Shimizu Eiji E Mishima Kazuo K Watanabe Koichiro K Takaesu Yoshikazu Y

Study Outcome 

Source Link: Visit source

Statistics
Citations :  American Psychiatric Association. Diagnostic and statistical Manual of Mental Disorders. 5th ed. 2013.
Authors :  19
Identifiers
Doi : 219
SSN : 2731-4553
Study Population
Male,Female
Mesh Terms
Adult
Other Terms
Benzodiazepine;Cognitive behavioral therapy for insomnia;Hypnotic; insomnia;Primary care
Study Design
Study Approach
Country of Study
Publication Country
England